Clinical Trial Update: Sofosbuvir/Pegylated-interferon Plus Ribavirin With HCV Genotype 4 [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating Sofosbuvir/Pegylated-interferon plus Ribavirin in Hepatitis C Virus Infection (Genotype 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon (pegylated interferon alfa)
• Ribavirin (ribavirin)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Beni-Suef University | Conditions: Hepatitis C Virus Infection | Phase 1, Phase 2 | Status: COMPLETED